4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0000950170-24-025915
EVP, COO acquired 9,167 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lamothe Jeffrey G. EVP, COO | 2024-03-02 | Option exercise | +5,500 | 33,837 | D | ||
| Lamothe Jeffrey G. EVP, COO | 2024-03-03 | Option exercise | +3,667 | 37,504 | D | ||
| Derivatives | |||||||
| Lamothe Jeffrey G. EVP, COO | 2024-03-02 | Option exercise · Restricted Stock Unit | −5,500 | 11,000 | D | ||
| Lamothe Jeffrey G. EVP, COO | 2024-03-03 | Option exercise · Restricted Stock Unit | −3,667 | 3,667 | D | ||
Loading xslF345X05/ownership.xml…